Doctor profile · Federal record
Dr. RISHI BAJAJ, MD
Interventional Cardiology Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Cardiovascular Disease Physician · SUFFERN, NY
- NPI 1003081985
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 23 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
79 ROUTE 59
SUFFERN, NY 109014913
(781) 530-0070 - Mailing address
-
76 FAIRWAYS DR
MIDDLETOWN, NY 109402666
Credentials & registration
- NPI registered
- April 2008 — 18 yrs on file
- Profile last updated
- June 13, 2023
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207RI0011X — NUCC code
- State license (1)
- New York #290772
- Medicaid
- NY #04863241
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1003081985. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,278
Distinct HCPCS
10
Medicare allowed
$794,330
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,590 | 34 | $0 | |
99309 |
Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 1,708 | 675 | $115 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 766 | 356 | $134 | |
93922 |
Ultrasound study of arm and leg arteries | 423 | 257 | $14 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 410 | 364 | $9 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 331 | 126 | $126 | |
93298 |
Evaluation of cardiac rhythm monitor system, remote up to 30 days | 230 | 57 | $28 | |
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 228 | 57 | $61 | |
93970 |
Ultrasound study of arm or leg veins with compression and maneuvers | 212 | 172 | $197 | |
93970 |
Ultrasound study of arm or leg veins with compression and maneuvers | 195 | 167 | $36 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 179. This provider delivers 63× the peer median.Open Payments
Industry payments received
All-time total
$522
Transactions
29
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 5 | $105.34 | |
| Merck Sharp & Dohme LLC | 5 | $80.73 | |
| Boston Scientific Corporation | 5 | $75.68 | |
| PFIZER INC. | 3 | $63.27 | |
| AstraZeneca Pharmaceuticals LP | 3 | $49.58 | |
| Kiniksa Pharmaceuticals International, plc | 2 | $42.88 | |
| Amgen Inc. | 2 | $32.97 | |
| Philips North America LLC | 1 | $20.88 | |
| Tactile Systems Technology Inc | 1 | $19.44 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15.63 | |
| CORDIS US CORP. | 1 | $15.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
684
Patients
364
Total drug cost
$107,237
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 119 | 61 | $2,520 |
| Atorvastatin Calcium | Generic | 105 | 58 | $1,598 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 83 | 41 | $1,235 |
| Furosemide | Generic | 55 | 33 | $290 |
| Rosuvastatin Calcium | Generic | 53 | 30 | $916 |
| Amlodipine Besylate | Generic | 41 | 21 | $318 |
| Ranolazine Er (Ranolazine) | Brand | 39 | 21 | $4,404 |
| Lisinopril | Generic | 29 | 19 | $332 |
| Bumetanide | Generic | 28 | 16 | $493 |
| Eliquis (Apixaban) | Brand | 25 | 15 | $28,226 |